Synonyms: FE202158
Compound class:
Peptide
Comment: Selepressin (FE 202158) is a peptidic vasopressin V1A receptor full agonist [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use ![]() |
Early stage clinical studies exploring efficacy to control fluid balance in patients with septic shock have been completed. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT01612676 | Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock | Phase 2 Interventional | Ferring Pharmaceuticals | 2 | |
NCT01000649 | Effects of the V1a Agonist FE 202158 in Patients With Septic Shock | Phase 2 Interventional | Ferring Pharmaceuticals | 2 |